Sonrotoclax, Zanubrutinib and CD20mab in Untreated MCL Patients
Clinical trial NCT06463691 · RECRUITING
Trial details
- NCT number
- NCT06463691
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2028-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.